MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 12, 2007, Pages 1473-1478

  Bendardaf, Riyad ^a   Buhmeida, Abdelbaset ^a   Ristamäki, Raija ^a   Syrjänen, Kari ^a   Pyrhönen, Seppo ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Colorectal cancer; Immunohistochemistry; Metastasis; MMP 1; Primary

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; INTERSTITIAL COLLAGENASE;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; STROMA CELL;

ANALYSIS OF VARIANCE; COLLAGENASES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PHENOTYPE; STATISTICS, NONPARAMETRIC;

EID: 36249007450     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701485449     Document Type: Article

References (32)

1. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
2. Kelly T, Yan Y, Osborne RL, Athota AB, Rozypal TL, Colclasure JC, et al. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998;16:501-12.
3. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
4. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, et al. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 1999;274:25371-8.
5. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999;80:733-43.
6. Ito T, Ito M, Shiozawa J, Naito S, Kanematsu T, Sekine I. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod Pathol 1999;12:669-74.
7. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
8. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-7.
9. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-66.
10. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34-45.
11. Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. Embo J 1995;14:908-17.
12. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999;43:S42-51.
13. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-8.
14. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-83.
15. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Nukui Y, et al. A prospective study of prognostic value of type IV collagenase activity in colorectal cancer tissue. Dig Dis Sci 1997;42:1660-5.
16. Yamaguchi A, Kurosaka Y, Ishida T, Nishimura G, Kanno M, Kosaka T, et al. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers. Dis Colon Rectum 1991;34:921-4.
17. Inoue T, Yashiro M, Nishimura S, Maeda K, Sawada T, Ogawa Y, et al. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int J Mol Med 1999;4:73-7.
18. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000;5:108-14.
19. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001;7:2344-6.
20. Bendardaf R, Lamlum H, Vihinen P, Ristamaki R, Laine J, Pyrhonen S. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology 2003;65:337-46.
21. van der Stappen JW, Hendriks T, Wobbes T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 1990;45:1071-8.
22. Otani Y, Okazaki I, Arai M, Kameyama K, Wada N, Maruyama K, et al. Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994;29:391-7.
23. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991;49:666-72.
24. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 2000;13:925-33.
25. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
26. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002;70:561-73.
27. Lochter A, Sternlicht MD, Werb Z, Bissell MJ. The significance of matrix metalloproteinases during early stages of tumor progression. Ann N Y Acad Sci 1998;857:180-93.
28. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005;1755:37-69.
29. Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie 2005;87:273-86.
30. van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003;82:539-48.
31. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005;7:513-20.
32. Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pNo. Cancer 2001;92:452.